Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2010 Filed Jan 19, 2010 18:33 UTC |
MUELLER PETEREVP Global R&D, CSO
|
Exercise / conversionStock Option · Derivative | 1,600 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-10-000001 · edgar.xml · derivative · entry 5 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,800 Underlying: Common Stock · 1,600 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| January 15, 2010 Filed Jan 19, 2010 18:33 UTC |
MUELLER PETEREVP Global R&D, CSO
|
SaleCommon Stock | 300 | $41.34 | $12,402.00 |
DisclosureSEC source: 0000875320-10-000001 · edgar.xml · nonDerivative · entry 3 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,874 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $41.34 (range $40.94 to $41.74). F4 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 15, 2010 Filed Jan 19, 2010 18:33 UTC |
MUELLER PETEREVP Global R&D, CSO
|
SaleCommon Stock | 1,300 | $40.09 | $52,117.00 |
DisclosureSEC source: 0000875320-10-000001 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,174 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $40.09 (range $39.83 to $40.37). F4 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| January 15, 2010 Filed Jan 19, 2010 18:33 UTC |
MUELLER PETEREVP Global R&D, CSO
|
Exercise / conversionCommon Stock | 1,600 | $10.41 | $16,656.00 |
DisclosureSEC source: 0000875320-10-000001 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2009 Filed Dec 11, 2009 17:10 UTC |
Wysenski NancyEVP & Chief Commercial Officer
|
GrantStock Option · Derivative | 300,000 | $0.00 Strike: $39.70 | $0.00 |
DisclosureSEC source: 0000875320-09-000108 · primary_doc.xml · derivative · entry 3 Wysenski Nancy · CIK 0001294596 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2019-12-08 F3 · shares: Stock option under 2006 Stock and Option Plan, vesting on 10/22/2014, subject to 20% acceleration upon receiving U.S. marketing approval for telaprevir; up to an additional 40% acceleration upon receiving U.S. approval for telaprevir if certain other performance goals are achieved; and acceleration of remaining unvested shares upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of any additional drug beyond telaprevir prior to December 31, 2012. Read SEC document |
| December 09, 2009 Filed Dec 11, 2009 17:10 UTC |
Wysenski NancyEVP & Chief Commercial Officer
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $39.70 | $0.00 |
DisclosureSEC source: 0000875320-09-000108 · primary_doc.xml · derivative · entry 2 Wysenski Nancy · CIK 0001294596 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2019-12-08 F2 · shares: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal installments over four years. Read SEC document |
| December 09, 2009 Filed Dec 11, 2009 17:10 UTC |
Wysenski NancyEVP & Chief Commercial Officer
|
GrantCommon Stock | 20,000 | $0.01 | $200.00 |
DisclosureSEC source: 0000875320-09-000108 · primary_doc.xml · nonDerivative · entry 1 Wysenski Nancy · CIK 0001294596 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Stock grant made under 2006 Stock and Option Plan Read SEC document |
| December 04, 2009 Filed Dec 9, 2009 15:49 UTC |
MUELLER PETEREVP Global R&D, CSO
|
Exercise / conversionStock Option · Derivative | 1,600 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-09-000101 · edgar.xml · derivative · entry 4 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,400 Underlying: Common Stock · 1,600 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| December 04, 2009 Filed Dec 9, 2009 15:49 UTC |
MUELLER PETEREVP Global R&D, CSO
|
SaleCommon Stock | 1,600 | $39.62 | $63,392.00 |
DisclosureSEC source: 0000875320-09-000101 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,874 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $39.62 (range $39.29 to $40.24). F3 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| December 04, 2009 Filed Dec 9, 2009 15:49 UTC |
MUELLER PETEREVP Global R&D, CSO
|
Exercise / conversionCommon Stock | 1,600 | $10.41 | $16,656.00 |
DisclosureSEC source: 0000875320-09-000101 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2009 Filed Nov 30, 2009 19:47 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,374 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000100 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,374 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| November 25, 2009 Filed Nov 30, 2009 19:47 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 6,374 | $39.43 | $251,326.82 |
DisclosureSEC source: 0000875320-09-000100 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $39.43 (range $39.20 to $39.66). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 25, 2009 Filed Nov 30, 2009 19:47 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,374 | $13.11 | $83,563.14 |
DisclosureSEC source: 0000875320-09-000100 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 20:07 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000098 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,374 Underlying: Common Stock · 6,400 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 20:07 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,100 | $39.82 | $83,622.00 |
DisclosureSEC source: 0000875320-09-000098 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $39.82 (range $39.68 to $40.29). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 20:07 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 4,300 | $39.51 | $169,893.00 |
DisclosureSEC source: 0000875320-09-000098 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,068,499 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $39.51 (range $39.27 to $39.67). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 18, 2009 Filed Nov 19, 2009 20:07 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000098 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2009 Filed Nov 20, 2009 21:37 UTC |
Silva Paul MV.P. and Corporate Controller
|
SaleCommon Stock | 719 | $39.70 | $28,544.30 |
DisclosureSEC source: 0000875320-09-000099 · edgar.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · V.P. and Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,625 Read SEC document |
| November 17, 2009 Filed Nov 19, 2009 19:57 UTC |
Kelly LisaSVP, Human Resources
|
SaleCommon Stock | 875 | $40.20 | $35,175.00 |
DisclosureSEC source: 0000875320-09-000097 · edgar.xml · nonDerivative · entry 1 Kelly Lisa · CIK 0001349077 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,980 F1 · kind: Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $40.20 (range $39.85 to 40.44). F3 · price: Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 11, 2009 Filed Nov 13, 2009 18:22 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000096 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,774 Underlying: Common Stock · 6,400 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| November 11, 2009 Filed Nov 13, 2009 18:22 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,600 | $41.30 | $107,380.00 |
DisclosureSEC source: 0000875320-09-000096 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $41.30 (range $41.00 to $41.73). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 11, 2009 Filed Nov 13, 2009 18:22 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 3,800 | $40.84 | $155,192.00 |
DisclosureSEC source: 0000875320-09-000096 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,068,995 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $40.84 (range $40.67 to $40.99). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 11, 2009 Filed Nov 13, 2009 18:22 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000096 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2009 Filed Nov 5, 2009 20:22 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000095 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,174 Underlying: Common Stock · 6,400 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| November 04, 2009 Filed Nov 5, 2009 20:22 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 3,700 | $37.54 | $138,898.00 |
DisclosureSEC source: 0000875320-09-000095 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $37.54(range $37.39 to $37.97). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 04, 2009 Filed Nov 5, 2009 20:22 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 2,700 | $37.25 | $100,575.00 |
DisclosureSEC source: 0000875320-09-000095 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,070,095 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $37.25 (range $36.86 to $37.38). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| November 04, 2009 Filed Nov 5, 2009 20:22 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000095 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2009 Filed Oct 28, 2009 18:02 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 5,300 | $33.46 | $177,338.00 |
DisclosureSEC source: 0000875320-09-000094 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $33.46 (range $33.28 to $33.60). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 27, 2009 Filed Oct 28, 2009 18:02 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 1,100 | $32.52 | $35,772.00 |
DisclosureSEC source: 0000875320-09-000094 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,071,695 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $32.52 (range $32.21 to $32.97). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 27, 2009 Filed Oct 28, 2009 18:02 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000094 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2009 Filed Oct 26, 2009 20:33 UTC |
Kelly LisaSVP, Human Resources
|
GrantStock Options · Derivative | 60,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0000875320-09-000090 · edgar.xml · derivative · entry 1 Kelly Lisa · CIK 0001349077 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2019-10-21 F1 · derivative.exercise_date: Stock option under 2006 Stock and Option Plan, vesting on 10/22/2014, subject to 20% acceleration upon receiving U.S. marketing approval for telaprevir; up to an additional 40% acceleration upon receiving U.S. approval for telaprevir if certain other performance goals are achieved; and 40% acceleration upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of an additional drug beyond telaprevir prior to December 31, 2012. Read SEC document |
| October 22, 2009 Filed Oct 26, 2009 20:31 UTC |
BOGER KENNETH SSVP & General Counsel
|
GrantStock Options · Derivative | 30,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0000875320-09-000089 · edgar.xml · derivative · entry 1 BOGER KENNETH S · CIK 0001046336 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2019-10-21 F1 · derivative.exercise_date: Stock option under 2006 Stock and Option Plan, vesting on 10/22/2014, subject to 100% acceleration upon receiving marketing approval from the FDA for telaprevir. Read SEC document |
| October 22, 2009 Filed Oct 26, 2009 20:35 UTC |
MUELLER PETERDirector · EVP, Global R&D, CSO
|
GrantStock Options · Derivative | 300,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0000875320-09-000091 · edgar.xml · derivative · entry 1 MUELLER PETER · CIK 0001256126 · Director · EVP, Global R&D, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2019-10-21 F1 · derivative.exercise_date: Stock option under 2006 Stock and Option Plan, vesting on 10/22/2014, subject to 20% acceleration upon receiving U.S. marketing approval for telaprevir; up to an additional 40% acceleration upon receiving U.S. approval for telaprevir if certain other performance goals are achieved; and 40% acceleration upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of an additional drug beyond telaprevir prior to December 31, 2012. Read SEC document |
| October 22, 2009 Filed Oct 26, 2009 20:37 UTC |
Sachdev AmitSVP, Corp Affairs & Pub Policy
|
GrantStock Options · Derivative | 60,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0000875320-09-000092 · edgar.xml · derivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Corp Affairs & Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2019-10-21 F1 · derivative.exercise_date: Stock option under 2006 Stock and Option Plan, vesting on 10/22/2014, subject to 20% acceleration upon receiving U.S. marketing approval for telaprevir; up to an additional 40% acceleration upon receiving U.S. approval for telaprevir if certain other performance goals are achieved; and 40% acceleration upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of an additional drug beyond telaprevir prior to December 31, 2012. Read SEC document |
| October 22, 2009 Filed Oct 26, 2009 20:38 UTC |
SMITH IAN FEVP & CFO
|
GrantStock Options · Derivative | 300,000 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0000875320-09-000093 · edgar.xml · derivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2019-10-21 F1 · derivative.exercise_date: Stock option under 2006 Stock and Option Plan, vesting on 10/22/2014, subject to 20% acceleration upon receiving U.S. marketing approval for telaprevir; up to an additional 40% acceleration upon receiving U.S. approval for telaprevir if certain other performance goals are achieved; and 40% acceleration upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of an additional drug beyond telaprevir prior to December 31, 2012. Read SEC document |
| October 21, 2009 Filed Oct 22, 2009 17:51 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000088 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,974 Underlying: Common Stock · 6,400 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| October 21, 2009 Filed Oct 22, 2009 17:51 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 6,400 | $33.17 | $212,288.00 |
DisclosureSEC source: 0000875320-09-000088 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $33.17 (range $32.89 to $34.47). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 21, 2009 Filed Oct 22, 2009 17:51 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000088 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2009 Filed Oct 28, 2009 18:02 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000094 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,574 Underlying: Common Stock · 6,400 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| October 19, 2009 Filed Oct 21, 2009 17:55 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,500 | $34.70 | $52,050.00 |
DisclosureSEC source: 0000875320-09-000087 · edgar.xml · nonDerivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,880 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $34.70 (range $34.56 to $34.83). F3 · price: Mr. Graves undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 14, 2009 Filed Oct 15, 2009 19:44 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000086 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,374 Underlying: Common Stock · 6,400 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| October 14, 2009 Filed Oct 15, 2009 19:44 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 6,400 | $34.20 | $218,880.00 |
DisclosureSEC source: 0000875320-09-000086 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $34.20 (range $33.90 to $34.54). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 14, 2009 Filed Oct 15, 2009 19:44 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000086 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2009 Filed Oct 8, 2009 18:05 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000085 · edgar.xml · derivative · entry 5 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,774 Underlying: Common Stock · 6,400 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| October 07, 2009 Filed Oct 8, 2009 18:05 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 6,400 | $33.77 | $216,128.00 |
DisclosureSEC source: 0000875320-09-000085 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $33.77 (range $33.50 to $34.11). F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| October 07, 2009 Filed Oct 8, 2009 18:05 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000085 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2009 Filed Oct 2, 2009 15:26 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionStock Options · Derivative | 6,400 | $0.00 Strike: $13.11 | $0.00 |
DisclosureSEC source: 0000875320-09-000084 · edgar.xml · derivative · entry 6 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,174 Underlying: Common Stock · 6,400 shares Expires 2009-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| September 30, 2009 Filed Oct 2, 2009 15:26 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 800 | $38.04 | $30,432.00 |
DisclosureSEC source: 0000875320-09-000084 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,066,395 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a wieghted average price of $38.04 (range $38.00 to $38.11). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 30, 2009 Filed Oct 2, 2009 15:26 UTC |
BOGER JOSHUA SDirector
|
SaleCommon Stock | 5,600 | $37.60 | $210,560.00 |
DisclosureSEC source: 0000875320-09-000084 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,067,195 F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $37.60 (range $37.06 to $37.99). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| September 30, 2009 Filed Oct 2, 2009 15:26 UTC |
BOGER JOSHUA SDirector
|
Exercise / conversionCommon Stock | 6,400 | $13.11 | $83,904.00 |
DisclosureSEC source: 0000875320-09-000084 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.